microdosing glp 1 athletes are sharing their GLP-1 winsβletβs break down what it really means for your journey. ππ #educationalpurposesonly GLP-1 Use in Athletes: Safety
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 100.Zhu X., Shen W., Wang Y., Jaiswal A., Ju Z., Sheng Q
In 2021, a higher dosage form of semaglutide, was approved for the treatment of obesity
Consistent with these findings, peripherally administered CCK induces cFos immunoreactivity in GLP-1-producing neurons of the hindbrain vagal complex of the NTS [354], and surgical vagal deafferentation reduces CCK-induced NTS neuronal cFos activation by approximately 50% [355]
Across randomized clinical trials of GLP-1 drugs involving thousands of participants, the most common side effects are consistently stomach-related including nausea, diarrhea, constipation, and vomiting, he says
(Aging is the exception!) Fact #4: You regain any pounds lost after stopping GLP-1 weight loss drugs because they dont fix the underlying reasons you gained the weight in the first place
Key takeaways Weight loss injections such as semaglutide (Wegovy), liraglutide (Saxenda), and tirzepatide (Zepbound) work by mimicking a hormone that helps curb hunger and increase feelings of fullness after eating
